Hot Products
| Catalog No. | Information |
| CFN98102 | Jujuboside B Jujuboside B has antitumor activity and the underlying mechanism via induction of apoptosis and autophagy. It reduces vascular tension endothelium-dependently by increasing Ca2+Influx and activating endothelial nitric oxide synthase, it has pharmacological effects on improving endothelial dysfunction and treating vascular diseases. |
| CFN93633 | Jujuboside B1 Jujubosides have hypnotic effect on normal rats, may be influenced by circadian rhythm and the serotonergic system may involve in the hypnotic effect of jujubosides, jujubosides may be good source of lead compounds for novel hypnotics. |
| CFN98103 | Jujuboside D Jujuboside D shows lipoxygenase-inhibiting activity. |
| CFN95702 | Justicidin A justicidin A is a nature product that could be isolated form Justicia procumbens. justicidin A decreases the level of Ku70 leading to translocation of Bax from the cytosol to mitochondria to induce apoptosis. justicidin A can be used in research of cancer |
| CFN95701 | Justicidin B Justicidin B is a potent anticancer lignan and proapoptotic agent. Justicidin B is also a bone resorption inhibitor, and has strong antiviral, fungicidal, antiprotozoal effects. Justicidin B significantly inhibits platelet aggregation. |
| CFN95704 | Justicidin C(Neojusticin B) Justicidin C is an antiviral lignan. Justicidin C shows strong antiviral activity against vesicular stomatitis virus and low cytotoxicity against rabbit lung cells (RL-33) |
| CFN92502 | Justiciresinol Justiciresinol is a natural product from Justicia glauca. |
| CFN92721 | Kadsulignan L Kadsulignan L shows in vitro antiviral effects on hepatitis B virus. It also shows moderate platelet-activating factor (PAF) antagonistic activities with the IC50 value of 2.6 x 10(-5) M. |
| CFN92725 | Kadsulignan N Standard reference |
| CFN97074 | Kadsuric acid Standard reference |
